Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After Stenting

UnknownOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

April 30, 2011

Conditions
Coronary Artery Disease
Interventions
DEVICE

Xience/Promus

Active prospective registration of patients receiving everolimus-eluting stent

DEVICE

Cypher

Retrospective historical controls that received sirolimus-eluting stent

Trial Locations (18)

Unknown

Dankook University Hospital, Cheonan

Soon Chun Hyang University Hospital Cheonan, Cheonan

Kwangju Veterans Hospital, Gwangju

Chonbuk National University Hospital, Iksan

Wonkwang University Hospital, Iksan

Inje University Ilsan Paik Hospital, Ilsan

Gachon Kil Medical Center, Inchon

Chungbuk National University Hospital, Jeonju

Presbyterian Medical Center, Jeonju

Gyeongsang National University Hospital, Jinju

Inje University Pusan Paik Hospital, Pusan

Seoul National University Bundang Hospital, Seongnam

Gangnam Severance Hospital, Seoul

Kyung Hee University Medical Center, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

Yonsei University Medical Center, Seoul

St. Carollo Hospital, Suncheon

Sponsors
All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

Boston Scientific Corporation

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT00960648 - Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After Stenting | Biotech Hunter | Biotech Hunter